|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3525 USD | -6.25% |
|
-12.96% | -70.00% |
| 05-27 | Kaos Capital acquires 4.9% stake in BioRestorative Therapies | RE |
| 05-26 | BioRestorative Completes Dosing in Phase 2 Trial of BRTX-100 to Treat Chronic Lumbar Disc Disease; Shares Rise | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -6.25% | -12.96% | +78.48% | +14.45% | -70.00% | -82.38% | -93.36% | -98.90% | -100.00% | 8.98M | |
| +1.03% | +2.30% | +12.23% | +27.21% | +9.32% | +54.92% | +111.78% | +206.81% | +6,761.65% | 56.42B | |
| +2.72% | +3.26% | -9.63% | +8.49% | +10.01% | +47.26% | +47.26% | -31.71% | - | 44.54B | |
| +1.12% | +2.79% | -3.33% | +0.49% | -4.89% | -13.71% | -17.53% | -62.05% | - | 22.9B | |
| +1.17% | +3.85% | -15.65% | -29.87% | -43.78% | +1.00% | +401.79% | +225.52% | +799.36% | 21.21B | |
| +3.81% | -5.07% | -7.77% | -11.50% | -1.15% | +12.00% | -29.52% | -75.10% | - | 16.4B | |
| +0.15% | +2.24% | -5.46% | -6.98% | -20.13% | +9.10% | -40.04% | -38.88% | +39.45% | 15.4B | |
| -0.69% | +0.82% | +7.42% | +29.05% | +21.22% | +27.17% | +178.31% | +131.20% | +619.92% | 13.35B | |
| +5.27% | +5.54% | -9.90% | +7.01% | +5.86% | +14.25% | - | - | - | 12.36B | |
| +1.61% | +1.28% | +33.47% | +42.92% | +101.91% | +92.88% | +215.31% | +1,034.84% | +421.38% | 11.15B | |
| +1.37% | -1.28% | -5.78% | +9.58% | -17.44% | +61.76% | +80.92% | +345.40% | - | 11.08B | |
| +0.15% | +1.96% | -5.72% | +35.47% | +12.25% | +359.43% | +110.63% | -16.00% | +1,173.85% | 10.5B | |
| +4.78% | -1.71% | -29.23% | -17.19% | -18.58% | -3.61% | +164.75% | +41.32% | - | 10.82B | |
| +7.11% | -5.15% | -26.07% | -9.38% | -19.90% | -30.51% | +687.08% | +105.43% | +49.04% | 10.87B | |
| -0.16% | +35.51% | +20.20% | +25.77% | +22.53% | +58.20% | +183.33% | - | - | 9.74B | |
| +1.27% | -1.86% | -6.23% | +16.92% | +10.40% | +111.30% | +95.08% | +233.41% | +754.45% | 9.52B | |
| +0.74% | -.--% | -.--% | -.--% | -.--% | -.--% | +37.41% | +236.02% | - | 8.19B | |
| -1.39% | +2.60% | -12.56% | -9.21% | +258.59% | +122.57% | +148.25% | -53.26% | - | 7.44B | |
| +7.04% | +5.74% | -21.44% | -13.52% | +3.54% | +29.31% | +133.70% | -40.22% | - | 7.93B | |
| +2.88% | +0.56% | -14.13% | -17.62% | -39.91% | - | - | - | - | 7.33B | |
| Average | +1.69% | +2.59% | -1.05% | +5.10% | +10.99% | +45.84% | +134.17% | +126.11% | +1,168.79% | 15.36B | |
| Weighted average by Cap. | +1.94% | +2.94% | -3.13% | +7.31% | +8.43% | +45.62% | +127.61% | +121.62% | +2,910.69% |
- Stock Market
- Stocks
- BRTX Stock
- Sector BioRestorative Therapies, Inc.
Select your edition
All financial news and data tailored to specific country editions
